Pre-eclampsia and inherited thrombophilia: A reappraisal

Seminars in Thrombosis and Hemostasis

Volumn 37, Issue 2, 2011, Pages 118-124

  Rath, Werner ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

conflicting data; confounders; inherited thrombophilia; management; Pre eclampsia

Indexed keywords

LIVER ENZYME; LOW MOLECULAR WEIGHT HEPARIN;

ACUTE KIDNEY FAILURE; ARTICLE; DISEASE ASSOCIATION; DISEASE SEVERITY; DISSEMINATED INTRAVASCULAR CLOTTING; ETHNICITY; HELLP SYNDROME; HEMOLYSIS; HUMAN; LUNG EDEMA; MATERNAL MORBIDITY; PERINATAL MORTALITY; PREECLAMPSIA; PREVALENCE; PRIORITY JOURNAL; RECURRENCE RISK; RISK ASSESSMENT; SCREENING; SOLUTIO PLACENTAE; SYSTEMATIC REVIEW; THROMBOPHILIA;

CASE-CONTROL STUDIES; CONFOUNDING FACTORS (EPIDEMIOLOGY); FACTOR V; FEMALE; HELLP SYNDROME; HUMANS; META-ANALYSIS AS TOPIC; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PREVALENCE; RECURRENCE; THROMBOPHILIA;

EID: 79952304697     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0030-1270337     Document Type: Article

References (39)

1. Kupferminc M J. Thrombophilia and pregnancy. Reprod Biol Endocrinol 2003 1 111
2. Sibai B M., Dekker G, Kupferminc M. Pre-eclampsia. Lancet 2005 365 9461 785-799 (Pubitemid 40311367)
3. Dekker G A., de Vries J I., Doelitzsch P M. et al. Underlying disorders associated with severe early-onset preeclampsia. Am J Obstet Gynecol 1995 173 4 1042-1048
4. Kupferminc M J., Eldor A, Steinman N et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med 1999 340 1 9-13 (Pubitemid 29024678)
5. Kupferminc M J., Fait G, Many A, Gordon D, Eldor A, Lessing J B. Severe preeclampsia and high frequency of genetic thrombophilic mutations. Obstet Gynecol 2000 96 1 45-49 (Pubitemid 30336278)
6. Franchini M. Haemostasis and pregnancy. Thromb Haemost 2006 95 3 401-413
7. Rodger M A., Paidas M, McLintock C et al. Inherited thrombophilia and pregnancy complications revisited. Obstet Gynecol 2008 112 2 Pt 1 320-324
8. Kujovich J L. Thrombophilia and pregnancy complications. Am J Obstet Gynecol 2004 191 2 412-424 (Pubitemid 39178692)
9. Stella C L., How H Y., Sibai B M. Thrombophilia and adverse maternal-perinatal outcome: controversies in screening and management. Am J Perinatol 2006 23 8 499-506 (Pubitemid 46535117)
10. Robertson L, Wu O, Langhorne P et al, Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study. Thrombophilia in pregnancy: a systematic review. Br J Haematol 2006 132 2 171-196 (Pubitemid 43381552)
11. Alfirevic Z, Roberts D, Martlew V. How strong is the association between maternal thrombophilia and adverse pregnancy outcome? A systematic review. Eur J Obstet Gynecol Reprod Biol 2002 101 1 6-14 (Pubitemid 34142238)
12. Morrison E R., Miedzybrodzka Z H., Campbell D M. et al. Prothrombotic genotypes are not associated with pre-eclampsia and gestational hypertension: results from a large population-based study and systematic review. Thromb Haemost 2002 87 5 779-785 (Pubitemid 34516601)
13. Kosmas I P., Tatsioni A, Ioannidis J PA. Association of Leiden mutation in factor V gene with hypertension in pregnancy and pre-eclampsia: a meta-analysis. J Hypertens 2003 21 7 1221-1228
14. Lin J, August P h. Genetic thrombophilias and preeclampsia: a meta-analysis. Obstet Gynecol 2005 105 1 182-192 (Pubitemid 40189930)
15. Dizon-Townson D, Miller C, Sibai B M. et al, National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. The relationship of the factor V Leiden mutation and pregnancy outcomes for mother and fetus. Obstet Gynecol 2005 106 3 517-524 (Pubitemid 41208783)
16. Larciprete G, Gioia S, Angelucci P A. et al. Single inherited thrombophilias and adverse pregnancy outcomes. J Obstet Gynaecol Res 2007 33 4 423-430 (Pubitemid 47222720)
17. Sohda S, Arinami T, Hamada H, Yamada N, Hamaguchi H, Kubo T. Methylenetetrahydrofolate reductase polymorphism and pre-eclampsia. J Med Genet 1997 34 6 525-526 (Pubitemid 27268138)
18. Brattström L, Wilcken D E., Ohrvik J, Brudin L. Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: the result of a meta-analysis. Circulation 1998 98 23 2520-2526 (Pubitemid 29001189)
19. Mello G, Parretti E, Marozio L et al. Thrombophilia is significantly associated with severe preeclampsia: results of a large-scale, case-controlled study. Hypertension 2005 46 6 1270-1274 (Pubitemid 43189722)
20. Kahn S R., Platt R, McNamara H et al. Inherited thrombophilia and preeclampsia within a multicenter cohort: the Montreal Preeclampsia Study. Am J Obstet Gynecol 2009 200 2 151, e1-e9 discussion e1-e5
21. Kist W J., Janssen N G., Kalk J J., Hague W M., Dekker G A., de Vries J I. Thrombophilias and adverse pregnancy outcomea confounded problem! Thromb Haemost 2008 99 1 77-85
22. Facchinetti F, Marozio L, Frusca T et al. Maternal thrombophilia and the risk of recurrence of preeclampsia. Am J Obstet Gynecol 2009 200 1 46, e1-e5
23. Sibai B M., el-Nazer A, Gonzalez-Ruiz A. Severe preeclampsia-eclampsia in young primigravid women: subsequent pregnancy outcome and remote prognosis. Am J Obstet Gynecol 1986 155 5 1011-1016 (Pubitemid 17176667)
24. van Rijn B B., Hoeks L B., Bots M L., Franx A, Bruinse H W. Outcomes of subsequent pregnancy after first pregnancy with early-onset preeclampsia. Am J Obstet Gynecol 2006 195 3 723-728 (Pubitemid 44292141)
25. Muetze S, Leeners B, Ortlepp J R. et al. Maternal factor V Leiden mutation is associated with HELLP syndrome in Caucasian women. Acta Obstet Gynecol Scand 2008 87 6 635-642 (Pubitemid 351882489)
26. Rigó J Jr, Nagy B, Fintor L et al. Maternal and neonatal outcome of preeclamptic pregnancies: the potential roles of factor V Leiden mutation and 5,10 methylenetetrahydrofolate reductase. Hypertens Pregnancy 2000 19 2 163-172 (Pubitemid 30436483)
27. von Tempelhoff G F., Heilmann L, Spanuth E, Kunzmann E, Hommel G. Incidence of the factor V Leiden-mutation, coagulation inhibitor deficiency, and elevated antiphospholipid-antibodies in patients with preeclampsia or HELLP-syndrome. Hemolysis, elevated liver-enzymes, low platelets. Thromb Res 2000 100 4 363-365
28. Nagy B, Hupuczi P, Papp Z. High frequency of methylenetetrahydrofolate reductase 677TT genotype in Hungarian HELLP syndrome patients determined by quantitative real-time PCR. J Hum Hypertens 2007 21 2 154-158
29. Demir S C., Evruke C, Ozgunen T, Kadayifci O, Altintas U, Kokangul S. The relationship between pregnancy induced hypertension and congenital thrombophilia. Saudi Med J 2006 27 8 1161-1166 (Pubitemid 47045006)
30. Muetze S, Eggermann T, Leeners B et al. The 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene is not associated with HELLP syndrome. J Thromb Thrombolysis 2009 27 2 141-145
31. Wiwanitkit V. Correlation between plasminogen activator inhibitor-1 4G/5G polymorphism and pre-eclampsia: an appraisal. Arch Gynecol Obstet 2006 273 6 322-324
32. Kupferminc M J., Fait G, Many A et al. Low-molecular-weight heparin for the prevention of obstetric complications in women with thrombophilias. Hypertens Pregnancy 2001 20 1 35-44 (Pubitemid 32672926)
33. Gris J C., Mercier E, Quéré I et al. Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder. Blood 2004 103 10 3695-3699 (Pubitemid 38596284)
34. Silver R M., Warren J E. Preconception counseling for women with thrombophilia. Clin Obstet Gynecol 2006 49 4 906-919 (Pubitemid 44691213)
35. James A H., Brancazio L R., Ortel T L. Thrombosis, thrombophilia, and thromboprophylaxis in pregnancy. Clin Adv Hematol Oncol 2005 3 3 187-197 (Pubitemid 41387381)
36. Bates S M., Greer I A., Pabinger I, Sofaer S, Hirsh J, American College of Chest Physicians. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008 133 6, Suppl 844S-886S (Pubitemid 351892978)
37. Duhl A J., Paidas M J., Ural S H. et al, Pregnancy and Thrombosis Working Group. Antithrombotic therapy and pregnancy: consensus report and recommendations for prevention and treatment of venous thromboembolism and adverse pregnancy outcomes. Am J Obstet Gynecol 2007 197 5 457, e1-e21
38. AWMF-Leitlinie 003/001. Prophylaxe der venösen Thromboembolie (VTE). Berlin, Germany German Society of Angiology April 1, 2009
39. Royal College of Obstetricians and Gynaecologists. Thrombosis and Embolism during Pregnancy and the Puerperium: Reducing the Risk. Green-top Guideline No. 37. London, United Kingdom Royal College of Obstetricians and Gynaecologists January 2010